Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesDyslipidemia and Risk of Coronary Heart Disease: Role of Lifestyle Approaches for Its Management
American Journal of Lifestyle Medicine, 07/17/09
Leon AS et al. – The purpose of this article is to review these contributions with an emphasis on dietary habits (particularly lipid intake), weight management, and aerobic exercise.
Related Articles
Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
Current Medical Research and Opinion, 10/05/09
Relevance Score: 85%
Corneal Arcus and Cardiovascular Risk Factors in Middle-Aged Subjects in Taiwan
The American Journal of the Medical Sciences, 10/14/09
Relevance Score: 84%
Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09
Relevance Score: 83%
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Lipids in Health and Disease, 10/13/09
Relevance Score: 83%
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09
Relevance Score: 82%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Subclinical Atherosclerosis In Young beta-thalassemia Major Patients
Hemoglobin, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Today in Coronary Artery Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel explanation for the cause of atrial fibrillation seen in atherosclerotic coronary artery disease: “Downstream inflammation” hypothesis
Medical Hypotheses, 12/11/09
Emerging inflammatory markers for assessing coronary heart disease risk
Current Cardiology Reports, 12/11/09
Comparison of the long-term prognostic value of Cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome
Atherosclerosis, 12/11/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 Polyunsaturated Fatty Acid in Primary and Secondary Cardiovascular Disease Prevention
AAOHN Journal, 12/11/09
Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case–control study in the northern Netherlands
European Heart Journal, 12/11/09
Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3',5'-Cyclic Monophosphate–Dependent Pathway
Hypertension, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor